Mark P. Lappe
Chief Executive Officer at Inhibrx Biosciences. Based in La Jolla, California.
- Rank
- 1939th of 14,644
- Companies held
- 1
- Largest holding
- INBX, 100.0% of total
- Latest SEC filing
- Oct 14, 2026
What the $72.1M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Inhibrx Biosciences INBX Common Stock | Through the Lappe Family Trust | 745,588 | $74.33 | $55.4M | 76.8% | Form 4, Oct 14, 2026 |
| Inhibrx Biosciences INBX Common Stock | Through Lappe Descendants' Trust | 170,000 | $74.33 | $12.6M | 17.5% | Form 4, Oct 14, 2026 |
| Inhibrx Biosciences INBX Common Stock | The Mark Paul Lappe Roth IRA | 54,865 | $74.33 | $4.1M | 5.7% | Form 4, Oct 14, 2026 |
Share counts are the amounts Mark P. Lappe reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 14, 2026 | Bought | INBX | 2,470 | $84.07 | $208K | View |
| Oct 14, 2026 | Bought | INBX | 2,470 | $85.00 | $210K | View |
| Oct 14, 2026 | Bought | INBX | 100 | $85.76 | $9K | View |
| Oct 14, 2026 | Bought | INBX | 2,449 | $84.07 | $206K | View |
| Oct 14, 2026 | Bought | INBX | 2,451 | $85.00 | $208K | View |
| Oct 14, 2026 | Bought | INBX | 100 | $85.76 | $9K | View |
| Sep 28, 2026 | Bought | INBX | 1,500 | $98.88 | $148K | View |
| Sep 28, 2026 | Bought | INBX | 3,000 | $101.70 | $305K | View |
| Sep 25, 2026 | Bought | INBX | 3,324 | $98.87 | $329K | View |
| Sep 25, 2026 | Bought | INBX | 2,176 | $99.60 | $217K | View |
| Sep 8, 2026 | Bought | INBX | 500 | $108.24 | $54K | View |
| Sep 8, 2026 | Bought | INBX | 9,681 | $112.28 | $1.1M | View |
| Sep 8, 2026 | Bought | INBX | 1,219 | $111.88 | $136K | View |
| Sep 8, 2026 | Bought | INBX | 5,895 | $99.29 | $585K | View |
| Sep 8, 2026 | Bought | INBX | 6,605 | $100.64 | $665K | View |
| Sep 8, 2026 | Bought | INBX | 1,100 | $107.12 | $118K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1936 | Ma Biu Chief Executive Officer, Luda Technology Group | $72.2M |
| 1937 | Daniel Benjamin Nash 10% owner, Silicon Valley Acquisition. Palo Alto, CA | $72.2M |
| 1938 | Juan Garoby Chief Technology Officer, Vista Energy, S.A.B. de C.V. | $72.2M |
| 1939 | Mark P. Lappe Chief Executive Officer, Inhibrx Biosciences. La Jolla, CA | $72.1M |
| 1940 | Lauro Emanuele CEO, Scorpio Tankers | $72.1M |
| 1941 | Eric M. Green President, CEO and Board Chair, West Pharmaceutical Services. Saint Paul, MN | $72.0M |
| 1942 | Shelby J. Butterfield Insider, Nelnet. Lincoln, NE | $72.0M |
Other Inhibrx Biosciences insiders
All INBX insiders- Jon Faiz Kayyem$56.1MDirector. #2327 overall
- Brendan P. Eckelman$35.2MChief Scientific Officer. #3315 overall
- Douglas G. Forsyth$16.9MDirector. #5878 overall
Questions
How much stock does Mark P. Lappe own?
Mark P. Lappe holds $72,133,771 in listed stock based on SEC filings and current prices, mostly Inhibrx Biosciences (INBX). That ranks 1939th on the Stock Rich List.
Is this Mark P. Lappe's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Mark P. Lappe last buy or sell stock?
The most recent open-market trade on file is a purchase of 2,470 INBX shares on Oct 14, 2026 at $84.07.